17-72122795-C-G
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_000346.4(SOX9):c.508C>G(p.Pro170Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P170L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000346.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SOX9 | NM_000346.4 | c.508C>G | p.Pro170Ala | missense_variant | 2/3 | ENST00000245479.3 | NP_000337.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SOX9 | ENST00000245479.3 | c.508C>G | p.Pro170Ala | missense_variant | 2/3 | 1 | NM_000346.4 | ENSP00000245479.2 | ||
SOX9-AS1 | ENST00000414600.1 | n.96+18890G>C | intron_variant | 3 | ||||||
ENSG00000288605 | ENST00000628742.2 | n.147-37750G>C | intron_variant | 5 | ||||||
ENSG00000288605 | ENST00000674828.1 | n.304-77271G>C | intron_variant |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Camptomelic dysplasia Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 20, 2022 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Pro170 amino acid residue in SOX9. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9002675). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SOX9 protein function. ClinVar contains an entry for this variant (Variation ID: 996802). This variant has not been reported in the literature in individuals affected with SOX9-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 170 of the SOX9 protein (p.Pro170Ala). - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, Heidelberg University | Apr 21, 2021 | The variant was not found in DNA extracted from the parents' blood samples (PS2), the variant is absent from controls (gnomAD; PM2), multiple lines of computational evidence support a deleterious effect (PP3) and it is localized at an amino acid site where different missense changes determined to be pathogenic have been seen before (PM5); therefore we classified it as pathogenic according to ACMG criteria. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | - | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Feb 01, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at